Caplight Directory>Companies>Xerient Pharma-preview>Xerient


Xerient Pharma

Xerient Pharma

Private
IsraelHealthcare & Life Scienceshttps://xerient.com

Last Round

Seed

Feb 1, 2025

Total Funding Raised

$4.17M

Company Overview

Xerient Pharma is a drug discovery company that develops radioprotective therapeutics and diagnostics designed to enhance the effectiveness and safety of pancreatic cancer treatment.

Sector

Healthcare & Life Sciences

Verticals

Clinical Trials, Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Revenue Share, Government Contracts

AI Layer

Non-AI

Keywords

radioprotective therapeuticradioprotectorpancreatic cancerdrug repurposingradiotherapyoncologyradiation injuryclinical-stage pharmaclinical-stage biotechgastrointestinal cancerdrug developmentsmall molecule drugoral therapeutic

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Xerient Pharma Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Xerient Pharma Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
SeedFeb 1, 2025
SeedJul 1, 2023
GrantJan 19, 2023
GrantAug 17, 2022
SeedMar 30, 2020
View all Funding Rounds

Xerient Pharma Investors

Notable investors and investment history

InvestorRounds
BIRD FoundationGrant
Southern Israel Bridging FundSeed
NewTech Investment HoldingsSeed
Peregrine VenturesSeed
Incentive IncubatorSeed
Cancer Prevention and Research Institute of TexasGrant
View all Investors

Xerient Pharma Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Xerient Pharma Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Xerient Pharma's valuation, stock price, and market status.

Firmographic Details

HeadquartersIsrael
Year Founded2019
Last FundingFeb 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.